CLOs on the Move

EmpiRx Health

www.empirxhealth.com

 
EmpiRx Health is challenging the status quo in today`s pharmacy benefit management industry by offering evidence-based clinical care programs that are aligned with our member`s needs. Our concierge model along with our proactive oversight and agile technology platform provide actionable insight to protect our clients and their members from ever-rising drug costs.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

The Washington Home

The Washington Home is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. The Washington Home is based in Hagerstown, MD. You can find more information on The Washington Home at www.thewashingtonhome.org

Cynvenio Biosystems Inc

Cynvenio is a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of cancer biomarkers in blood.

Health Choice Network

Health Choice Network (HCN) is a national model of a successful collaboration of community health centers (CHCs) and one of several HRSA-sponsored Health Center Controlled Networks. HCN is addressing health care disparities, providing health information technologies and strengthening the financial position of the community health care system. Founded in 1994 as a 501c(3) organization, HCN was created and is governed by its members who comprise a minority-based Board of Directors. Network members maintain their vital community orientation by retaining their local-governing, consumer-majority Boards of Directors. Community Health Centers that own and control the Network operate more efficiently, can deliver care more effectively and are working together to care for more patients.

Cardionomic

Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.

SironaHealth

SironaHealth is a South Portland, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.